FIELD: medicine.
SUBSTANCE: method refers to medicine, specifically to diagnostic methods. Substance of method of fatty liver disease diagnostics in patients suffering from chronic hepatitis C consists as follows: blood serum of the patient is analysed for apolipoprotein A-1 and apolipoprotein B-100. High level of apolipoprotein B-100 within 1.15-1.17 g/l and low level of apolipoprotein A-1 within 0.89-0.92 g/l indicates fatty liver disease in patients suffering from chronic hepatitis C. Application of method enables to diagnose fatty liver disease in patients suffering from chronic hepatitis C, thus providing timely choice of therapeutic measures of treatment.
EFFECT: diagnose fatty liver disease in patients suffering from chronic hepatitis C, thus providing timely choice of therapeutic measures of treatment.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR VERIFYING CHRONIC HEPATIC PATHOLOGY IN PATIENTS WITH ARTERIAL HYPERTENSION | 2013 |
|
RU2547246C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR CHRONIC VIRAL HEPATITIS AND FATTY LIVER DISEASE IN PATIENTS SUFFERING DYSLIPIDEMIA SYNDROME | 2014 |
|
RU2542457C1 |
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF CHRONIC VIRAL HEPATITIS AND FATTY LIVER DISEASE IN PATIENTS WITH DYSLIPIDEMIA SYNDROME | 2014 |
|
RU2552299C1 |
| METHOD OF SCREENING STUDY OF RISK OF DEVELOPING LIVER DAMAGE OF DIFFERENT ORIGINS | 2017 |
|
RU2675015C1 |
| METHOD OF DIAGNOSING LIVER AFFECTION IN CASE OF ATHEROGENIC DYSLIPIDEMIA | 2008 |
|
RU2403567C2 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF STEATOSIS AND NON-ALCOHOLIC STEATOHEPATITIS IN FEMALES | 2020 |
|
RU2744021C1 |
| METHOD OF PREDICTING THE EFFECTIVENESS OF LITHOLYSIS IN CHOLELITHIASIS IN COMBINATION WITH NON-ALCOHOLIC FATTY LIVER DISEASE | 2023 |
|
RU2813033C1 |
| METHOD FOR DIAGNOSIS INTRAHEPATIC CHOLESTASIS AT POLYVIRAL HEPATITIS | 2008 |
|
RU2397711C2 |
| METHOD FOR PREDICTING SEVERE HEPATIC FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE | 2021 |
|
RU2765847C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF ISCHEMIC HEART DISEASE | 2012 |
|
RU2520755C1 |
